Alnylam Pharmaceuticals
ALNY
#728
Rank
A$48.74 B
Marketcap
A$364.31
Share price
2.55%
Change (1 day)
-46.56%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company